The healthcare industry is facing dramatic changes in government policy with huge consequences impacting the economics and survival of many providers. Last fall, Rivkin Radler entered into a Strategic Affiliation with Liberty Partners Group, a leading healthcare lobbying firm, to afford our clients access to key government officials and agencies.
Please join us on January
On Sunday, November 30, from 2:00 PM to 5:00 PM, Rivkin Radler partner Sean Simensky will present the program “Buying Smart: What You Need to Know About Acquiring a Dental Practice,” at the 2025 Greater NY Dental Meeting alongside Mohamed Abdullah of Bank of America, Robert Malandruccolo of Bank of America, Bill Murray of Wicklow
In October, two medical transportation companies were charged with or indicted for fraud in New York.
The owner of Pearl Transit Corp. (“Pearl”), Jael Watts, was accused of running a sham transportation service that supposedly provided rides for persons with disabilities and seniors in Westchester, Putnam, Rockland, and Suffolk counties. In 2024, the
An article in the September 22 issue of Part B News, “Failed restrictive covenant case signals a warning to practices,” discussed a recent New Jersey case in which a practice sued to enforce a restrictive covenant against a physician whose employment it had terminated. Rivkin Radler’s Tamika Hardy was quoted in the
On Thursday, September 18, in the next installment of Rivkin Radler’s Health Law Executive Briefings, Chris Kutner and Ashley Algazi will present “How to Handle Payer Record Request and Subsequent Demand for Alleged Overpayments.”
The presentation will provide a comprehensive review of the issues and best practices for responding to, and defending against, payer audits.
On September 18, Rivkin Radler’s Jeff Kaiser will participate on a panel at Practising Law Institute’s Life Sciences 2025: Navigating Legal Challenges in Drug and Device Industries. Jeff’s panel is entitled “Enforcement Trends Impacting the Drug and Device Industries.”
Held at PLI’s NY Conference Center, located at 1177 Avenue of the Americas, the program will
An article in the August issue of Healthcare Risk Management, “DOJ Targeting Healthcare for False Claims Act Enforcement,” discussed recent enforcement activity by the U.S. Department of Justice (DOJ) under the False Claims Act (FCA). Rivkin Radler’s Jeff Kaiser was quoted in the article.
Jeff predicted that the FCA will continue to
An article in the June 9 issue of Part B News, “To ease doctor-departing woes, write careful terms into the contract,” discussed best practices for medical practices’ employment contracts with their physician employees. Rivkin Radler’s Norton Travis was quoted in the article.
Norton suggested that practices try to enforce restrictive covenants where
Jeff Kaiser’s article, “COVID-19 Pandemic Fraud Enforcement Efforts Overview,” was published in the LexisNexis legal research tool, Practical Guidance.
In the article, Jeff offers a comprehensive overview of enforcement efforts related to COVID-19 pandemic fraud.
Sign up to receive Rivkin Rounds at www.RivkinRounds.com.
On May 1, a whistleblower filed a complaint under the federal False Claims Act (FCA) against Aetna, Elevance Health (formerly Anthem) and Humana alleging that the insurers paid hundreds of millions of dollars in illegal kickbacks to induce brokers including GoHealth, eHealth and SelectQuote (the “Brokers”) to steer beneficiaries to their Medicare Advantage plans. While